Key Findings

---

Introduction

At Westpoint Pharma, we evaluate pharmaceutical excipients not only as individual materials, but also by how they perform in practical formulation combinations.

Mannitol and microcrystalline cellulose (MCC) are commonly used together in direct compression because their functional properties can complement each other.

In the Westpoint Pharma excipient portfolio, DESU^® Mannitol 200SD from Westpoint Pharma can be used either alone for direct compression or in combination with DESU^® Microcrystalline Cellulose PH-102 from Westpoint Pharma.

By contrast, DESU^® Mannitol 50C has limited suitability for direct compression when used alone, but its tablet-forming performance can be improved when combined with DESU^® MCC PH-102.

This article explains how mannitol and MCC work together and how different DESU^® mannitol grades behave during compression.

---

Why Combine Mannitol with MCC?

Mannitol and MCC provide different but complementary functions in tablet formulations.

Mannitol

• Good powder flowability
• Low hygroscopicity
• Cooling sweetness and improved mouthfeel
• Suitability for chewable, dispersible and orally disintegrating tablets

Microcrystalline Cellulose

• Dry binding functionality
• Plastic deformation during compression
• Improved tablet mechanical strength
• Good disintegration performance
• Improved process robustness in direct compression

When used together, MCC can compensate for the relatively weaker compactibility of some crystalline mannitol grades, while mannitol can improve the sensory profile of formulations containing MCC.

For direct compression, this combination can help balance manufacturability, tablet strength and mouthfeel.

---

Can DESU^® Mannitol 200SD Be Used Alone for Direct Compression?

Yes.

DESU^® Mannitol 200SD is a spray-dried pharmaceutical mannitol grade from Westpoint Pharma. Its particle structure supports favorable powder flow and compression performance, allowing it to be used alone in many direct compression formulations.

It can also be combined with DESU^® MCC PH-102 when additional dry-binding capacity, tablet strength or formulation flexibility is required.

In the reported study, DESU^® Mannitol 200SD and DESU^® MCC PH-102 were evaluated at two mannitol-to-MCC ratios:

• 5:5
• 3:7

At both ratios, the tablet hardness-versus-compression-force curves of DESU^® Mannitol 200SD were very similar to those of the tested European 200SD reference material.

---

How Does DESU^® Mannitol 200SD Perform with MCC?

At a 5:5 mannitol-to-MCC ratio, tablet hardness increased as compression force increased from approximately 5 kN to 25 kN.

The hardness curves for DESU^® Mannitol 200SD and the tested European reference grade remained closely aligned across the evaluated compression range.

At a 3:7 ratio, overall tablet hardness increased while the two hardness curves continued to show similar trends.

These results indicate that DESU^® Mannitol 200SD showed strong compatibility with DESU^® MCC PH-102 and performance comparable to the tested European reference grade under the reported conditions.

---

Can DESU^® Mannitol 50C Be Used Alone?

DESU^® Mannitol 50C behaves differently from DESU^® Mannitol 200SD because its more crystalline and brittle structure provides less standalone tablet-forming capacity.

When DESU^® Mannitol 50C was compressed alone, capping occurred when the main compression force exceeded approximately 10 kN in the reported study.

This indicates that the grade has limited suitability for use alone in direct compression under those test conditions.

For this reason, DESU^® Mannitol 50C is better suited to formulations where another excipient can contribute plastic deformation and dry-binding functionality.

---

How Does MCC Improve DESU^® Mannitol 50C?

When DESU^® Mannitol 50C was combined with DESU^® MCC PH-102 at a 5:5 ratio, tablet mechanical strength increased significantly as compression force increased.

No capping was observed in the reported combination study.

In this system, DESU^® MCC PH-102 acts as a dry binder and plastic-deforming carrier, helping compensate for the brittle behavior of crystalline mannitol.

This complementary mechanism improves overall compactibility and makes DESU^® Mannitol 50C more practical for tablet manufacturing when used together with MCC.

---

DESU^® Mannitol 200SD vs DESU^® Mannitol 50C

The appropriate mannitol grade depends on the formulation and manufacturing process.

Choose DESU^® Mannitol 200SD When:

• Direct compression is the preferred manufacturing process
• Mannitol is expected to provide a major portion of the filler function
• Good powder flowability is important
• Strong standalone compression performance is preferred
• The formulation may also include MCC for additional dry binding or formulation flexibility

Choose DESU^® Mannitol 50C When:

• Mannitol will be combined with MCC or another plastic-deforming excipient
• The formulation uses a dry binder
• Additional plastic deformation is required
• Capping must be controlled
• Mannitol is not expected to provide the full tablet-forming function by itself

---

Why Is the Mannitol-MCC Combination Useful in Direct Compression?

Direct compression requires excipients to perform several functions simultaneously. The powder must flow consistently, fill dies uniformly, form mechanically strong tablets and maintain appropriate disintegration and sensory properties.

DESU^® Mannitol 200SD contributes favorable powder flow, mouthfeel and direct-compression performance, while DESU^® MCC PH-102 contributes dry binding, plastic deformation and tablet strength.

For crystalline grades such as DESU^® Mannitol 50C, the contribution of MCC becomes even more important because it can compensate for limited standalone compactibility.

This complementary approach reflects Westpoint Pharma's formulation-focused view of pharmaceutical excipients: selecting materials according to functional performance rather than chemical identity alone.

---

Typical Applications

• Direct compression tablets
• Chewable tablets
• Orally disintegrating tablets
• Dispersible tablets
• Formulations requiring improved mouthfeel
• Formulations requiring higher tablet strength
• High-speed tablet manufacturing
• Formulations requiring a balance between powder flow and compactibility

---

Formulation Considerations

Although the reported data demonstrate good compatibility between DESU^® Mannitol and DESU^® MCC PH-102, the optimal ratio should be determined for each formulation.

Important formulation variables include:

• API properties
• Mannitol grade
• MCC grade
• Mannitol-to-MCC ratio
• Lubricant concentration
• Compression force
• Tablet hardness target
• Disintegration requirements

The 5:5 and 3:7 ratios discussed in this article reflect the reported experimental conditions and should not be interpreted as universal formulation recommendations.

---

Conclusion

Mannitol and microcrystalline cellulose can provide a complementary excipient system for direct compression.

DESU^® Mannitol 200SD from Westpoint Pharma can be used either alone or in combination with DESU^® MCC PH-102, while DESU^® Mannitol 50C benefits more strongly from MCC because of its limited standalone tablet-forming ability.

Under the reported conditions, combining DESU^® Mannitol 50C with DESU^® MCC PH-102 improved tablet mechanical strength and eliminated the observed capping issue. DESU^® Mannitol 200SD also showed strong compatibility with MCC and performance comparable to the tested European reference grade.

DESU^® Mannitol + DESU^® MCC — Complementary Excipient Performance for Direct Compression.

---

About Westpoint Pharma

Westpoint Pharma is a pharmaceutical excipients manufacturer focused on functional excipients for formulation development and pharmaceutical manufacturing.

The Westpoint Pharma portfolio includes DESU^® microcrystalline cellulose, pharmaceutical mannitol and other functional excipient solutions for oral solid dosage forms.

Learn more about Westpoint Pharma and its pharmaceutical excipient solutions at www.westpointexcipients.com .